The trademark application KELMEVDI was filed by Teva Pharmaceuticals International GmbH, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on October 2, 2025, and still open for oppositions.
The application was filed in English (German was selected as the second language).